More News

29 Mar 2007 Oxford BioMedica and Sanofi-Aventis Enter Global Licensing Agreement to Develop and Commercialise TroVax for Cancer
29 Mar 2007 MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance
29 Mar 2007 Wockhardt receives US FDA approval for anti-inflammatory injection
29 Mar 2007 Wockhardt receives US FDA approval for diuretic injection, Second FDA approval in a week
29 Mar 2007 Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million
28 Mar 2007 Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
28 Mar 2007 Taro Receives Tentative Approval for Ciclopirox Topical Solution, 8% (Nail Lacquer) ANDA
28 Mar 2007 BrainCells Inc. and Lundbeck Form CNS Drug Research Collaboration
28 Mar 2007 Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
27 Mar 2007 Schering-Plough and Merck to Develop Another New Cholesterol Lowering Medicine
27 Mar 2007 Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma
27 Mar 2007 Cephalon, Inc. (CEPH) Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
24 Mar 2007 NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
23 Mar 2007 Topigen and Novagali enter into strategic collaboration for allergic ocular diseases and allergic rhinitis
23 Mar 2007 Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
23 Mar 2007 Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in Japan to Merck & Co., Inc.
23 Mar 2007 MilleGen and LFB Sign Research Partnership Agreement to Develop New Generation of Therapeutic Monoclonal Antibodies
23 Mar 2007 VASTox plc Acquires DanioLabs Ltd and Dextra Laboratories Ltd to Strengthen Its Drug Discovery Pipeline and Pharmaceutical Services Business
22 Mar 2007 Fralex Therapeutics Inc. initiates pivotal trial for chronic pain associated with fibromyalgia
22 Mar 2007 BioLineRx In-Licenses Novel Peptide for the Treatment of Inflammatory Diseases
22 Mar 2007 Medtronic Announces Strategic Agreement with Osteogenix, Incorporated
22 Mar 2007 Synovics Pharmaceuticals Files ANDA for Generic Hydroxyzine
22 Mar 2007 Eisai's Dramatic Leap towards Biologic Therapeutics Evidenced by the Acquisition
21 Mar 2007 Abraxis BioScience to Initiate Two Phase I/II Clinical Trials with nab-docetaxel in Hormone Refractory Prostate and Metastatic Breast Cancer
21 Mar 2007 Wockhardt to market painkiller in the US, Sixteenth US FDA-approved product

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top